ArticleImmunotherapy advances2025

Cytokine-induced memory-like NK cells combined with Tafasitamab demonstrate efficacy against B-cell acute lymphoblastic leukemia.

Dimitrios Filioglou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.